1. Home
  2. ATGL vs RGNX Comparison

ATGL vs RGNX Comparison

Compare ATGL & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ATGL
  • RGNX
  • Stock Information
  • Founded
  • ATGL 2017
  • RGNX 2008
  • Country
  • ATGL Hong Kong
  • RGNX United States
  • Employees
  • ATGL N/A
  • RGNX N/A
  • Industry
  • ATGL
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ATGL
  • RGNX Health Care
  • Exchange
  • ATGL Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • ATGL 407.0M
  • RGNX 424.8M
  • IPO Year
  • ATGL 2023
  • RGNX 2015
  • Fundamental
  • Price
  • ATGL $21.70
  • RGNX $9.13
  • Analyst Decision
  • ATGL
  • RGNX Strong Buy
  • Analyst Count
  • ATGL 0
  • RGNX 8
  • Target Price
  • ATGL N/A
  • RGNX $31.75
  • AVG Volume (30 Days)
  • ATGL 3.9K
  • RGNX 583.4K
  • Earning Date
  • ATGL 01-01-0001
  • RGNX 07-31-2025
  • Dividend Yield
  • ATGL N/A
  • RGNX N/A
  • EPS Growth
  • ATGL N/A
  • RGNX N/A
  • EPS
  • ATGL N/A
  • RGNX N/A
  • Revenue
  • ATGL $1,590,148.00
  • RGNX $156,718,000.00
  • Revenue This Year
  • ATGL N/A
  • RGNX $327.08
  • Revenue Next Year
  • ATGL N/A
  • RGNX N/A
  • P/E Ratio
  • ATGL N/A
  • RGNX N/A
  • Revenue Growth
  • ATGL 42.17
  • RGNX 80.70
  • 52 Week Low
  • ATGL $1.15
  • RGNX $5.04
  • 52 Week High
  • ATGL $57.32
  • RGNX $15.36
  • Technical
  • Relative Strength Index (RSI)
  • ATGL 43.53
  • RGNX 55.09
  • Support Level
  • ATGL $21.51
  • RGNX $8.14
  • Resistance Level
  • ATGL $23.90
  • RGNX $8.94
  • Average True Range (ATR)
  • ATGL 0.85
  • RGNX 0.49
  • MACD
  • ATGL 0.10
  • RGNX 0.06
  • Stochastic Oscillator
  • ATGL 37.32
  • RGNX 87.61

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd operates through its subsidiaries, which are established cloud-based IT solution service providers in Hong Kong. Its Operating Subsidiaries utilize its analytic skills, programming skills, artificial intelligence technologies and technological know-how to provide comprehensive solutions designed to optimize the business performance of customers, meet various industry-specific operational challenges of customers and create new business opportunities for customers. The Operating Subsidiaries provide services for customers from a variety of industries, including consulting, real estate, architectural design, carpark management, electronic payment services, logistics, investments, retail, textiles, wholesale and distribution, etc.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: